查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
成像臨床研究機構市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按提供的服務、成像方式、臨床試驗階段、應用、終端用戶、公司和地區分類
市場調查報告書
商品編碼
1303139

成像臨床研究機構市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按提供的服務、成像方式、臨床試驗階段、應用、終端用戶、公司和地區分類

Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2017-2027 Segmented By Services Offered, By Imaging Modality, By Clinical Trial Phase, By Application, By End User, By company & By Region
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內，全球影像臨床研究機構（CRO）市場預計將出現令人矚目的成長。主要因素包括臨床試驗數量的成長，研發支出的持續成長，以及技術的廣泛進步推動市場的成長。醫學成像在新型生命科學產品的臨床進展中發揮有效作用。生物技術和製藥業的擴張，以及為開發治療各種疾病的新藥而增加的研發投資，可能會推動市場行業成長。促進市場成長的其他因素，是研發活動的增加，研發支出的增加，成像過程自動化的增加，成像技術使用的增加和計算能力的增強，以及合併和戰略收購數量的增加。

醫學成像的年度臨床試驗數量增加支持市場成長。

由於臨床研究的增加，臨床試驗的數量不斷增加，促進了市場的成長。成像臨床研究機構透過提供大量的資訊和對關鍵領域的洞察力來幫助研究人員。他們為醫療設備、生物技術和製藥等各種行業增加品質、成本效益和製造能力。醫學成像在臨床試驗中的意義越來越大，推動了市場的成長。根據Keosys醫學影像的文章，2018年，每年進行的臨床試驗總數在2020年比2010年幾乎加倍。

研發活動和支出的成長促進市場成長

研究和開發（R&D）活動的增加促進市場的成長。放射學和成像科學領域的研究不斷增加，有助於產生關鍵技術，並磨練出使用設備識別和治療人類異常和疾病的現代技術。如今，在醫學成像的幫助下，各種臨床研究用來評估醫療、手術和行為干涉。另外，研發支出的持續成長也促進了市場的成長。

在成像CRO過程中擴大採用自動化

在過去的幾年裡，技術的快速進步推動市場的成長。影像學CRO過程中的自動化等進步對生物技術和製藥業產生巨大影響。成像CRO過程中的自動化使該過程有效和高效；同時，它也有助於控制錯誤和減少時間。因此，成像過程中擴大採用自動化，鼓勵了市場的成長。例如，2021年，Abbott公司宣布其最新的光學相干斷層掃描（OCT）成像平台獲得了FDA的許可，該平台由該公司新的Ultreon軟體操作。這種先進的成像軟體將OCT與人工智慧相結合，為醫生提供了一個增強的、全面的冠狀動脈血流和堵塞物的視圖，以幫助醫生決策並提供最佳的治療路線。

可用的客製化方案

利用給定的市場資料，TechSci Research根據公司的具體需求提供客製化服務。本報告有以下客製化選項：

公司資訊

  • 其他市場參與者（最多5家）的詳細分析和概況。

目錄

第一章：產品概述

第二章：研究方法

第三章：執行摘要

第四章：COVID-19對全球影像臨床研究組織（CRO）市場的影響

第五章：客戶的聲音

第六章：全球影像學臨床研究組織（CRO）市場展望

  • 市場規模與預測
    • 按價值計算
  • 市場佔有率與預測
    • 按提供的服務（成像採集和方案開發、應用設計、圖像採集和品質控制、數位圖像轉換、支持和維護、其他）分類
    • 按成像方式（電腦斷層掃描（CT）、磁共振成像（MRI）、正電子發射斷層掃描（PET）、其他）分類
    • 按臨床試驗階段（第1階段、第2階段、第3階段）
    • 按應用（腫瘤學、神經學、心血管學、眼科、其他）分類
    • 按終端用戶（製藥和生物技術公司、醫療設備製造商、學術和研究機構、其他）
    • 按地區
    • 按公司分類（2021年）
  • 市場地圖

第七章：北美影像臨床研究組織（CRO）市場前景

  • 市場規模與預測
    • 按價值分類
  • 市場佔有率與預測
    • 按提供的服務分類
    • 按成像方式分類
    • 按臨床試驗階段分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 美國
    • 墨西哥

第八章：歐洲影像臨床研究組織（CRO）市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按提供的服務分類
    • 按成像方式分類
    • 按臨床試驗階段分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區影像臨床研究組織（CRO）市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按提供的服務分類
    • 按成像方式分類
    • 按臨床試驗階段分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第十章：南美影像臨床研究組織（CRO）市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按提供的服務分類
    • 按成像方式分類
    • 按臨床試驗階段分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲影像臨床研究組織（CRO）市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按提供的服務分類
    • 按成像方式分類
    • 按臨床試驗階段分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • MEA: 國家分析
    • 南非影像學臨床研究組織(CRO)
    • 沙烏地阿拉伯影像學臨床研究組織（CRO）
    • 阿拉伯聯合大公國影像學臨床研究組織(CRO)
    • 土耳其影像學臨床研究組織(CRO)
    • 埃及影像學臨床研究組織(CRO)

第十二章：市場動態

  • 驅動力
  • 挑戰

第十三章：市場趨勢與發展

第十四章：競爭格局

  • Laboratory Corporation of America Holdings
  • IXICO PLC
  • ICON plc
  • The Micron Group
  • Medpace Holdings, Inc.
  • Radiant Sage LLC
  • Biomedical Systems Corporation
  • Worldcare Clinical, LLC
  • Imaging Endpoints LLC
  • Parexel International Corporation

第十五章：戰略建議

簡介目錄
Product Code: 14156

The global imaging clinical research organization (CRO) market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the growing number of clinical trials, continuous growth in R&D spending, and extensive advancement in technology are impelling the growth of the market. Medical imaging plays an effective role in the clinical advancement of novel life science products. The expansion of the biotechnology and pharmaceutical industries, along with increased research and development investments for developing new drugs to treat various diseases, is likely to drive the market industry growth. The other factors supporting the market's growth are, rise in R&D activities, increasing R&D expenditure, a rise in automation of imaging process, increasing usage of imaging technology and the enhanced power of computing, and a growing number of mergers and strategic acquisitions.

An increase in the Annual Number of Clinical Trials with Medical Imaging supports Market Growth.

A growing number of clinical trials due to the rise in clinical research is augmenting the growth of the market. Imaging Clinical Research Organizations help researchers by providing massive amounts of information and insights into key areas. They are adding quality, cost-effectiveness, and manufacturing capacity to various industries such as medical devices, biotechnology, and pharmaceutical. The growing significance of medical imaging in clinical trials is fueling the growth of the market. According to a Keosys Medical Imaging article, in 2018, the total number of clinical trials performed each year almost doubled in 2020 compared to 2010.

Growth in R&D Activities and spending to foster the Market Growth

The rise in research and development (R&D) activities is bolstering the growth of the market. Rising research in the field of radiology and imaging sciences are helping to generate critical technologies, as well as honed modern techniques for using equipment to identify and treat abnormalities and disease in humans. Nowadays, various clinical studies are done to evaluate medical, surgical, and behavioral interventions with the help of medical imaging. Also, continuous growth in R&D spending is facilitating the growth of the market.

Increasing Adoption of Automation in Imaging CRO Process

Over the past few years, rapid advancements in technology are propelling the growth of the market. Advancements such as automation in the Imaging CRO process are making a huge impact on the biotechnology and pharmaceutical industries. Automation in the imaging CRO process makes the process effective and efficient; also, it helps to control errors and minimize time. Thus, the increasing adoption of automation in the imaging process encourages the growth of the market. For instance, in 2021, Abbott announced that it had received FDA clearance for the latest optical coherence tomography (OCT) imaging platform operated by the company's new Ultreon Software. This advanced imaging software combines OCT with artificial intelligence to offer physicians an enhanced, comprehensive view of coronary blood flow and blockages to aid physician decision-making and offer the best route for treatment.

Market Segmentation

The global imaging clinical research organization (CRO) market is segmented into services offered, imaging modality, clinical trial phase, application, end user, and company. Based on the services offered, the market is divided into imaging acquisition and protocol development, application design, image collection, and quality control, digital image conversion, support and maintenance, and others. Based on imaging modality, the market is divided into computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET), and others. Based on the clinical trial phase, the market is divided into Phase 1, phase 2, and Phase 3. Based on application, the market is divided into oncology, neurology, cardiovascular, ophthalmology, and others. Based on end-user, the market is divided into pharmaceutical & biotechnology companies, medical device manufacturers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of clinical studies in the country.

Market Players

Laboratory Corporation of America Holdings, IXICO PLC, ICON plc, The Micron Group, Medpace Holdings, Inc., Radiant Sage LLC, Biomedical Systems Corporation, Worldcare Clinical, LLC, Imaging Endpoints LLC, and Parexel International Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global imaging clinical research organization (CRO) market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Imaging Clinical Research Organization (CRO) Market, By Services Offered:

  • Imaging Acquisition and Protocol Development
  • Application Design
  • Image Collection and Quality Control
  • Digital Image Conversion
  • Support and Maintenance
  • Others

Imaging Clinical Research Organization (CRO) Market, By Imaging Modality:

  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Others

Imaging Clinical Research Organization (CRO) Market, By Clinical Trial Phase:

  • Phase 1
  • Phase 2
  • Phase 3

Imaging Clinical Research Organization (CRO) Market, By application:

  • Oncology
  • Neurology
  • Cardiovascular
  • Ophthalmology
  • Others

Imaging Clinical Research Organization (CRO) Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic & Research Institutions
  • Others

Imaging Clinical Research Organization (CRO) Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Imaging Clinical Research Organization (CRO) Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Imaging Clinical Research Organization (CRO) Market

5. Voice of Customer

6. Global Imaging Clinical Research Organization (CRO) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Services Offered (Imaging Acquisition and Protocol Development, Application Design, Image Collection and Quality Control, Digital Image Conversion, Support and Maintenance, Others)
    • 6.2.2. By Imaging Modality (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Others)
    • 6.2.3. By Clinical Trial Phase (Phase 1, Phase 2, Phase 3)
    • 6.2.4. By Application (Oncology, Neurology, Cardiovascular, Ophthalmology, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Imaging Clinical Research Organization (CRO) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Services Offered
    • 7.2.2. By Imaging Modality
    • 7.2.3. By Clinical Trial Phase
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Services Offered
        • 7.3.1.2.2. By Imaging Modality
        • 7.3.1.2.3. By Clinical Trial Phase
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Services Offered
        • 7.3.2.2.2. By Imaging Modality
        • 7.3.2.2.3. By Clinical Trial Phase
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Services Offered
        • 7.3.3.2.2. By Imaging Modality
        • 7.3.3.2.3. By Clinical Trial Phase
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Imaging Clinical Research Organization (CRO) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Services Offered
    • 8.2.2. By Imaging Modality
    • 8.2.3. By Clinical Trial Phase
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Services Offered
        • 8.3.1.2.2. By Imaging Modality
        • 8.3.1.2.3. By Clinical Trial Phase
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Services Offered
        • 8.3.2.2.2. By Imaging Modality
        • 8.3.2.2.3. By Clinical Trial Phase
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Services Offered
        • 8.3.3.2.2. By Imaging Modality
        • 8.3.3.2.3. By Clinical Trial Phase
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Services Offered
        • 8.3.4.2.2. By Imaging Modality
        • 8.3.4.2.3. By Clinical Trial Phase
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Services Offered
        • 8.3.5.2.2. By Imaging Modality
        • 8.3.5.2.3. By Clinical Trial Phase
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Imaging Clinical Research Organization (CRO) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Services Offered
    • 9.2.2. By Imaging Modality
    • 9.2.3. By Clinical Trial Phase
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Services Offered
        • 9.3.1.2.2. By Imaging Modality
        • 9.3.1.2.3. By Clinical Trial Phase
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Services Offered
        • 9.3.2.2.2. By Imaging Modality
        • 9.3.2.2.3. By Clinical Trial Phase
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Services Offered
        • 9.3.3.2.2. By Imaging Modality
        • 9.3.3.2.3. By Clinical Trial Phase
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Services Offered
        • 9.3.4.2.2. By Imaging Modality
        • 9.3.4.2.3. By Clinical Trial Phase
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Services Offered
        • 9.3.5.2.2. By Imaging Modality
        • 9.3.5.2.3. By Clinical Trial Phase
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Imaging Clinical Research Organization (CRO) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Services Offered
    • 10.2.2. By Imaging Modality
    • 10.2.3. By Clinical Trial Phase
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Services Offered
        • 10.3.1.2.2. By Imaging Modality
        • 10.3.1.2.3. By Clinical Trial Phase
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Services Offered
        • 10.3.2.2.2. By Imaging Modality
        • 10.3.2.2.3. By Clinical Trial Phase
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Services Offered
        • 10.3.3.2.2. By Imaging Modality
        • 10.3.3.2.3. By Clinical Trial Phase
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Imaging Clinical Research Organization (CRO) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Services Offered
    • 11.2.2. By Imaging Modality
    • 11.2.3. By Clinical Trial Phase
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Services Offered
        • 11.3.1.2.2. By Imaging Modality
        • 11.3.1.2.3. By Clinical Trial Phase
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Services Offered
        • 11.3.2.2.2. By Imaging Modality
        • 11.3.2.2.3. By Clinical Trial Phase
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Services Offered
        • 11.3.3.2.2. By Imaging Modality
        • 11.3.3.2.3. By Clinical Trial Phase
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Services Offered
        • 11.3.4.2.2. By Imaging Modality
        • 11.3.4.2.3. By Clinical Trial Phase
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Services Offered
        • 11.3.5.2.2. By Imaging Modality
        • 11.3.5.2.3. By Clinical Trial Phase
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. IXICO PLC
  • 14.3. ICON plc
  • 14.4. The Micron Group
  • 14.5. Medpace Holdings, Inc.
  • 14.6. Radiant Sage LLC
  • 14.7. Biomedical Systems Corporation
  • 14.8. Worldcare Clinical, LLC
  • 14.9. Imaging Endpoints LLC
  • 14.10. Parexel International Corporation

15. Strategic Recommendations